IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 55 filers reported holding IRADIMED CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $417,430 | +79108.7% | 9,500 | -20.8% | 0.00% | 0.0% |
Q1 2024 | $527 | -13.2% | 12,000 | -6.2% | 0.00% | -33.3% |
Q4 2023 | $607 | +7.1% | 12,800 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $567 | +0.7% | 12,800 | +8.5% | 0.00% | +50.0% |
Q2 2023 | $563 | -64.9% | 11,800 | -71.1% | 0.00% | 0.0% |
Q1 2023 | $1,605 | +261.5% | 40,800 | +159.9% | 0.00% | 0.0% |
Q4 2022 | $444 | -99.9% | 15,700 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $471,000 | -11.5% | 15,700 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $532,000 | -19.8% | 15,700 | +6.1% | 0.00% | 0.0% |
Q1 2022 | $663,000 | -14.6% | 14,800 | -11.9% | 0.00% | -33.3% |
Q4 2021 | $776,000 | +94.5% | 16,800 | +41.2% | 0.00% | +50.0% |
Q3 2021 | $399,000 | +14.3% | 11,900 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $349,000 | +25.5% | 11,900 | +10.2% | 0.00% | 0.0% |
Q1 2021 | $278,000 | +13.0% | 10,800 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $246,000 | -2.4% | 10,800 | -8.5% | 0.00% | 0.0% |
Q3 2020 | $252,000 | -48.3% | 11,800 | -43.8% | 0.00% | -50.0% |
Q2 2020 | $487,000 | +13.5% | 21,000 | +4.5% | 0.00% | 0.0% |
Q1 2020 | $429,000 | -8.5% | 20,100 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $469,000 | -44.4% | 20,100 | -50.0% | 0.00% | 0.0% |
Q3 2019 | $844,000 | +105.4% | 40,200 | +100.0% | 0.00% | 0.0% |
Q2 2019 | $411,000 | -21.7% | 20,100 | +7.5% | 0.00% | 0.0% |
Q1 2019 | $525,000 | +14.9% | 18,700 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $457,000 | -24.6% | 18,700 | +14.5% | 0.00% | -33.3% |
Q3 2018 | $606,000 | +551.6% | 16,333 | +263.0% | 0.00% | – |
Q2 2018 | $93,000 | – | 4,500 | – | 0.00% | – |
Q3 2016 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q2 2016 | $78,000 | +14.7% | 3,600 | 0.0% | 0.00% | – |
Q1 2016 | $68,000 | -32.0% | 3,600 | 0.0% | 0.00% | – |
Q4 2015 | $100,000 | +376.2% | 3,600 | +300.0% | 0.00% | – |
Q3 2015 | $21,000 | +5.0% | 900 | 0.0% | 0.00% | – |
Q2 2015 | $20,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |